AI’s true promise is turning clinical development from a bottleneck into a throughput engine for human health. Drug discovery ...
The Foundation Model, Soon to be Available on AWS Marketplace, Moves the Industry Beyond Drug Discovery, Ushering in a New Frontier for AI in Pharma Focused on Clinical Trials NEW YORK--(BUSINESS WIRE ...
In today’s ACT Brief, we cover the FDA approval of oral Wegovy based on Phase III OASIS 4 results, recap the most-read ...
SAN FRANCISCO--(BUSINESS WIRE)--Rune Labs, the leader in precision medicine for Parkinson’s disease (PD), today announced the launch of a clinical program with Parkinson’s Foundation to accelerate the ...
AI-enabled imaging company Aidoc announced it has secured $150 million in financing. The round was led by General Catalyst and Square Peg, with participation from NVentures (NVIDIA’s venture capital ...
Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and expectations from regulators, payers, and patients continue to rise. Meanwhile, ...
New drug development is a race against the clock as soon as the first patents are filed, and understanding the potential timings from first-in-human studies to regulatory approval is crucial for ...
The Magee-Womens Research Institute — Erie's lab is located so close to labor and delivery rooms that, at times, you can hear the cries of newborn babies. It's no coincidence that the lab, where ...
The Foundation for the National Institutes of Health has added eight rare diseases to its gene therapy-focused clinical trial portfolio, betting that a public-private partnership can grease an ...
The Damon Runyon Cancer Research Foundation has named five new Damon Runyon Clinical Investigators. The recipients of this prestigious award are outstanding, early-career physician-scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results